Client & Alumni News

OraSure Earns $205M Federal Contract for Rapid COVID-19 test

The company expects to ramp up production during the remainder of 2021 to meet the contract, and so it expects most of the revenue from the contract to be coming in during 2022.

The InteliSwab, which received Emergency Use Authorization from the Food & Drug Administration, is used by swiping the lower nostril and gives rapid test results. The test does not need to be administered by a professional making it more convenient in non-medical settings. Via Lehigh Valley Business